Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Child Neurology
  • Track 1-2Sports Neurology
  • Track 1-3Neuroethics
  • Track 1-4Vascular Neurology
  • Track 1-5Stem cells and regenerative Neurology
  • Track 1-6Functional Disorders and Behavioral Neurology
  • Track 1-7Neuropsychiatric disturbances
  • Track 1-8Investigating biomarkers
  • Track 1-9Neurocognitive disorder
  • Track 1-10Childhood and adolescent psychiatry
  • Track 1-11Fundamentals of the clinical evaluation
  • Track 2-1Hyper reflexia
  • Track 2-2Spasticy
  • Track 2-3Spine muscular atropies
  • Track 2-4Neuromuscular junction disorder
  • Track 2-5LambertEaton syndrome
  • Track 2-6Muscular dystrophy
  • Track 2-7Findings in the field of Neuromuscular medicine
  • Track 2-8Amyotrophic lateral sclerosis
  • Track 2-9Multiple sclerosis
  • Track 2-10Myasthenia gravis
  • Track 2-11Spinal muscular atrophy
  • Track 2-12Botulinum neurotoxin
  • Track 2-13Care Practice and Awarness
  • Track 2-14Anterior,Central & Posterior Cord syndrome
  • Track 2-15Therapeutic Targets & Mechanisms for Treatment
  • Track 3-1Plastic Neurosurgery
  • Track 3-2 Post-surgical neuralgias
  • Track 3-3Tumour and metastatis
  • Track 3-4Oncological neurosurgery
  • Track 3-5Spine neurosurgery
  • Track 3-6Current neurosurgery methods
  • Track 3-7Vascular Neurology
  • Track 3-8Neuroanaesthesia and surgery
  • Track 3-9Advancement in personalized medicine
  • Track 4-1Muscular dystrophy
  • Track 4-2 Spinal Muscular Atrophy (SMA)
  • Track 4-3Friedreichs Ataxia
  • Track 4-4Mitochondrial Myopathies
  • Track 4-5Metabolic Myopathies
  • Track 5-1Epidemiology of Brain stroke
  • Track 5-2Risk factors of Stroke
  • Track 5-3Haemorrage stroke and ischemic stroke
  • Track 5-4Amyotrophic lateral sclerosis (ALS)
  • Track 5-5Imaging, diagnosis and acute stroke management
  • Track 5-6Novel Insights for Parkinsons disease
  • Track 6-1Bipolar Disorder
  • Track 6-2Neuropathic pain syndromes
  • Track 6-3Accessory nerve disorder
  • Track 6-4CNS disorder and structural defects
  • Track 6-5Facial nerve paralysis
  • Track 6-6Meningitis
  • Track 6-7Therapies for genetic disorders
  • Track 7-1Neural tissue engineering
  • Track 7-2Biomarker in Neuroimaging
  • Track 7-3Advancement in brain computer interface
  • Track 7-4Current research in neural imaging
  • Track 7-5Biological neural networking
  • Track 7-6Neurobiotics
  • Track 7-7Biomolecular therapies in Neural regeneration
  • Track 8-1Neuropsychiatric disturbances
  • Track 8-2Investigating biomarkers
  • Track 8-3Developmental risk factors
  • Track 8-4Neurocognitive disorder
  • Track 8-5Childhood and adolescent psychiatry
  • Track 8-6Fundamentals of the clinical evaluation
  • Track 8-7Advancement in personalized medicine
  • Track 9-1Anti-anxiety Drugs
  • Track 9-2Recent Drug development
  • Track 9-3Neuroimmuno pharmacology
  • Track 9-4Latest advancement in Neuropharmacologcal therapy
  • Track 9-5Neuro chemical interaction
  • Track 10-1Brain Stroke
  • Track 10-2Autism and Schizophrenia
  • Track 10-3Neuropharmacology and Therapeutics
  • Track 10-4Therapies for genetic disorders
  • Track 11-1Cerebral aneurysms
  • Track 11-2Cerebral Arteriosclerosis
  • Track 11-3Cerebral atrophy
  • Track 11-4Cerebral Cavernous malformation
  • Track 11-5Cerebral hypoxia
  • Track 11-6Cerebral palsy
  • Track 11-7Cerebro Oculo Facio Skeletal syndrome
  • Track 11-8Accessory nerve disorder
  • Track 11-9Pseudotumor Cerebri
  • Track 11-10CSF Complications
  • Track 12-1Neuro Endocrine cells
  • Track 12-2Hypothalamus
  • Track 12-3Neurohypophysis
  • Track 12-4Adrenal glands
  • Track 12-5Pituitary glands
  • Track 13-1Ataxia
  • Track 13-2Dystonia
  • Track 13-3Essential Tremors
  • Track 13-4Atypical Parkinsonisms
  • Track 14-1Behavioural Neuroscience
  • Track 14-2Neuroglial Cells
  • Track 14-3Synaptic activities
  • Track 14-4Neurotransmitters
  • Track 14-5Synaptic Plasticity
  • Track 14-6Neuromyelitis Optica
  • Track 15-1Attention Deficit Hyperactivity Disorder (ADHD)
  • Track 15-2Autism Spectrum Disorders (ASD)
  • Track 15-3Cerebral palsy
  • Track 15-4Intellectual disability
  • Track 15-5Speech disorder (dislalia)
  • Track 15-6Comprehension disorder
  • Track 15-7Expression disorder
  • Track 15-8Impairments in vision and hearing
  • Track 16-1Psycho Oncology
  • Track 16-2Radiation therapy
  • Track 16-3Neuropharmacology of cancer
  • Track 16-4Glioblastoma survival rate
  • Track 16-5Pediatric oncologist
  • Track 16-6Inoperable brain tumor
  • Track 16-7Craniopharyngioma
  • Track 16-8Brain tumor
  • Track 16-9Butterfly glioma
  • Track 17-1Scoliosis
  • Track 17-2Kyphosis
  • Track 17-3Flatback syndrome
  • Track 17-4Scheuerman’s disease
  • Track 17-5Osteoporosis
  • Track 17-6Duchenne Muscular Dystrophy
  • Track 18-1Somatic nervous system
  • Track 18-2Autonomic nervous system
  • Track 18-3Peripheral neuropathy
  • Track 18-4Nerve Block
  • Track 18-5Nerve tumours
  • Track 18-6Carpal tunnel syndrome
  • Track 18-7Sarcoidosis
  • Track 19-1Etiology and Epidemiology
  • Track 19-2Epilepsy in Women and Inborn
  • Track 19-3Epilepsy and Neuropsychology
  • Track 19-4Epilepsia
  • Track 19-5Cortical dysplasia and Epilepsy
  • Track 19-6Impact of the Epilepsies on daily life
  • Track 19-7Prevention and Management of Epilepsy
  • Track 20-1Vascular Dementia
  • Track 20-2Traumatic brain injury
  • Track 20-3Diagnosis and Symptoms
  • Track 20-4Imaging Techniques
  • Track 20-5 Geriatrics and Cognitive Disorder
  • Track 20-6Alzheimer’s clinical trials and studies
  • Track 21-1Anxiety
  • Track 21-2Brain Machine Interface
  • Track 21-3Synaptic Pruning
  • Track 21-4Obsessive behavior
  • Track 21-5Brain-derived neurotrophic factor (BDNF)
  • Track 22-1Huntington disease
  • Track 22-2Cancer genetics
  • Track 22-3Gene defect and diseases
  • Track 22-4Genome wide association studies
  • Track 22-5Biochemical genetics
  • Track 22-6Gene mutation and disease
  • Track 22-7Genetic engineering and Gene sequencing